Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

EMA committee hands down positive opinion for Ravicti

Sep. 28, 2015

Coq2 and Plac8 genes in obesity-related type 2 diabetes

Sep. 28, 2015

Glucose-dependent peptide shows promise for diabetes

Sep. 25, 2015

Helsinn Healthcare divulges ghrelin receptor antagonists

Sep. 25, 2015

ZP-I-98: a novel GIP receptor agonist

Sep. 23, 2015

Bristol-Myers Squibb patents MGAT2 inhibitors

Sep. 23, 2015

Clinical outcomes reported for triheptanoin in rare metabolic disorders

Sep. 23, 2015

SOFIA transgenic pig enables study of insulin secretory granule processing

Sep. 23, 2015

Taro launches Keveyis for primary hyperkalemic and hypokalemic periodic paralysis

Sep. 22, 2015

Clinical effect of K-877 may be superior to fibrate drugs on the market

Sep. 22, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...